代谢组学
化学
生物化学
肝损伤
代谢途径
谷胱甘肽
代谢物
磷酸戊糖途径
天然产物
新陈代谢
鞘脂
代谢组
烟酰胺
葡萄糖醛酸盐
糖酵解
药理学
糖异生
硫胺素
细胞内
半胱氨酸代谢
信号转导
脂肪酸代谢
嘌呤代谢
肝细胞
牛磺酸
作者
Yu Peng,Yuanhan Zhong,武喜娃,Liyun Wen,Guangpeng Liu,Shouwen Zhang,Bingbing Xu,梁永红,Huiliang Huang,Junwei He,Yong Feng,Jinxiang Zeng,Jian Liang
标识
DOI:10.1002/cbdv.202502806
摘要
Elucidating mechanisms of natural product metabolites is key to safer, more effective drugs against drug-induced liver injury (DILI). This study used cellular metabolomics to investigate hepatoprotective effects of three structurally similar platycoside metabolites-platycodigenin (PDN), 3-O-β-D-glucopyranosyl platycodigenin (OPDN), and polygalacic acid (POLA)-against APAP-induced liver injury. Using AML-12 hepatocytes challenged with APAP, intracellular metabolites were profiled by UHPLC-LTQ-Orbitrap mass spectrometry (ESI+ and ESI-), followed by PCA/OPLS-DA to identify differential metabolites and MetaboAnalyst-based pathway enrichment. All three converged on core pathways: glycerophospholipid, purine, and amino sugar/nucleotide sugar metabolism, preserving membrane integrity, mitigating oxidative stress, and modulating inflammation. Unique actions emerged: PDN/OPDN targeted sphingolipid metabolism (apoptosis regulation); OPDN/POLA enhanced glutathione and nicotinamide pathways (antioxidant defenses); OPDN exclusively regulated arachidonic acid metabolism (inflammation/immune function); POLA uniquely modulated thiamine and pentose phosphate pathways (redox/energy homeostasis). These findings highlight structural tailoring's role in diversifying mechanisms, supporting multi-component herbal paradigms, and providing a metabolomic foundation for optimized platycoside-derived DILI therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI